semaglutide and cancer How May Reduce The Risk Of Obesity-Linked Cancers GLP-1 Weight Loss Drugs May

diffusum and their multi-target mechanisms of action against gastric cancer

If pancreatitis was confirmed, tirzepatide must not be restarted

Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity: A Randomized Clinical Trial

10.3390/nu12113317 Nutrients

China: Demand for GLP-1 companion products in China is projected to grow at around an 11.7% CAGR through 2036, supported by rapid expansion of domestic GLP-1 user base for weight management, and formulation technologies, and growing focus on high-quality and science-backed companion products for muscle preservation and GI side-effect management